Posts Tagged ‘industry’
Do we believe the tobacco industry lied to us? Association with smoking behavior in a military population
Despite the dangers of smoking, tobacco companies continue to impede tobacco control efforts through deceptive marketing practices. Media campaigns that expose these practices have been effective in advancing anti-industry attitudes and reducing smoking initiation among young people, yet the association between knowledge of industry practices and smoking cessation and relapse has not been studied. In a large military sample entering Air Force Basic Military Training (BMT), where tobacco use is prohibited, we investigated (i) the prevalence of agreement with a statement that tobacco companies have misled the public about the health consequences of smoking and (ii) the association of this acknowledgement with smoking status upon entry into BMT (N = 36 013). At baseline, 56.6% agreed that tobacco companies have been deceptive, and agreement was a strong predictor of smoking status [smokers less likely to agree, odds ratio (OR) = 0.39, P < 0.01]. At 12-month follow-up, we examined the association between industry perception at baseline and current smoking status (N = 20 672). Recruits who had been smoking upon entry into BMT and who had acknowledged industry deception were less likely to report current smoking (OR = 0.84, P = 0.01). These findings suggest that anti-industry attitudes may affect smoking relapse following cessation.
Cannabis Science Receives FDA Industry Guidelines For Mapping Out Its Initial Drugs Offerings For FDA Submission And Testing
Cannabis Science Inc. (OTCBB: CBIS), an emerging pharmaceutical cannabis company, is pleased to report that the FDA has provided the Company with documentation to assist the Company to review and plan its initial applications to get its first drug into formal testing. Cannabis Science, Inc. President & CEO Dr.
Hospital Industry May Cut Billions To Help With Reform
The hospital industry is close to agreeing to cut $150 billion to $170 billion over the next decade as part of a deal with the White House and congressional democrats to help pay for health care reform. While not final, the deal could be announced within days. Kaiser Health News reports: “A critical feature is an agreement on phasing in the Medicare and Medicaid cuts.
Drug Industry Increases Lobbying Efforts And Targets Democrats
The drug industry began ramping up its lobbying efforts in 2003, when Medicare Part D began, and now is targeting Democrats. CQ Politics reports: “The industry is increasingly employing Democratic lobbyists with ties to the Obama administration and congressional leaders such as Sen. Max Baucus, D-Mont., chairman of the Senate Finance Committee.
Democrats, Republicans, Health Industry ‘Players’ Consider Compromises In Health Debate, According To Journal Editorial, Times
An editorial and an opinion piece on Monday addressed health care reform. Summaries appear below. Editorial Democrats’ insistence on the budget reconciliation option for health care reform is meant “to coerce Republicans into rubber-stamping liberal policy,” namely a government-run public insurance option, a Wall Street Journal editorial states.
Rx Drug Compare
Translator
By N2H